Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, sold KURA on Sep 28, 2026
Data as of Oct 16
▼ SELL$48.4K4,607 shares at $10.50Thomas James Doyle SVP, Finance & AccountingKURA Kura Oncology, Inc.
- Traded
- Sep 28, 2026
- Disclosed
- Sep 29, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KURA since disclosure
−16.0%
after the sale
Similar stocks (XLV) since disclosure
+3.5%
XLV — its sector index fund
Change in closing price from Sep 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.